214 related articles for article (PubMed ID: 34650037)
1. The Hsc70 disaggregation machinery removes monomer units directly from α-synuclein fibril ends.
Schneider MM; Gautam S; Herling TW; Andrzejewska E; Krainer G; Miller AM; Trinkaus VA; Peter QAE; Ruggeri FS; Vendruscolo M; Bracher A; Dobson CM; Hartl FU; Knowles TPJ
Nat Commun; 2021 Oct; 12(1):5999. PubMed ID: 34650037
[TBL] [Abstract][Full Text] [Related]
2. Human Hsp70 Disaggregase Reverses Parkinson's-Linked α-Synuclein Amyloid Fibrils.
Gao X; Carroni M; Nussbaum-Krammer C; Mogk A; Nillegoda NB; Szlachcic A; Guilbride DL; Saibil HR; Mayer MP; Bukau B
Mol Cell; 2015 Sep; 59(5):781-93. PubMed ID: 26300264
[TBL] [Abstract][Full Text] [Related]
3. Cooperative amyloid fibre binding and disassembly by the Hsp70 disaggregase.
Beton JG; Monistrol J; Wentink A; Johnston EC; Roberts AJ; Bukau BG; Hoogenboom BW; Saibil HR
EMBO J; 2022 Aug; 41(16):e110410. PubMed ID: 35698800
[TBL] [Abstract][Full Text] [Related]
4. Truncation-Driven Lateral Association of α-Synuclein Hinders Amyloid Clearance by the Hsp70-Based Disaggregase.
Franco A; Cuéllar J; Fernández-Higuero JÁ; de la Arada I; Orozco N; Valpuesta JM; Prado A; Muga A
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884786
[TBL] [Abstract][Full Text] [Related]
5. Molecular dissection of amyloid disaggregation by human HSP70.
Wentink AS; Nillegoda NB; Feufel J; Ubartaitė G; Schneider CP; De Los Rios P; Hennig J; Barducci A; Bukau B
Nature; 2020 Nov; 587(7834):483-488. PubMed ID: 33177717
[TBL] [Abstract][Full Text] [Related]
6. Hsc70 protein interaction with soluble and fibrillar alpha-synuclein.
Pemberton S; Madiona K; Pieri L; Kabani M; Bousset L; Melki R
J Biol Chem; 2011 Oct; 286(40):34690-9. PubMed ID: 21832061
[TBL] [Abstract][Full Text] [Related]
7. A sudden collapse: the disaggregation of amyloid fibres.
Couzijn S; Nollen EA
EMBO J; 2022 Aug; 41(16):e111700. PubMed ID: 35791595
[TBL] [Abstract][Full Text] [Related]
8. HspB1 and Hsc70 chaperones engage distinct tau species and have different inhibitory effects on amyloid formation.
Baughman HER; Clouser AF; Klevit RE; Nath A
J Biol Chem; 2018 Feb; 293(8):2687-2700. PubMed ID: 29298892
[TBL] [Abstract][Full Text] [Related]
9. Identification of protein interfaces between α-synuclein, the principal component of Lewy bodies in Parkinson disease, and the molecular chaperones human Hsc70 and the yeast Ssa1p.
Redeker V; Pemberton S; Bienvenut W; Bousset L; Melki R
J Biol Chem; 2012 Sep; 287(39):32630-9. PubMed ID: 22843682
[TBL] [Abstract][Full Text] [Related]
10. Applying chaperones to protein-misfolding disorders: molecular chaperones against α-synuclein in Parkinson's disease.
Chaari A; Hoarau-Véchot J; Ladjimi M
Int J Biol Macromol; 2013 Sep; 60():196-205. PubMed ID: 23748003
[TBL] [Abstract][Full Text] [Related]
11. Fine-tuning of the Hsc70-based Human Protein Disaggregase Machinery by the Distinctive C-terminal Extension of Apg2.
Cabrera Y; Bernardo-Seisdedos G; Dublang L; Albesa-Jové D; Orozco N; Viguera AR; Millet O; Muga A; Moro F
J Mol Biol; 2022 Nov; 434(22):167841. PubMed ID: 36167183
[TBL] [Abstract][Full Text] [Related]
12. α-Synuclein aggregation at low concentrations.
Afitska K; Fucikova A; Shvadchak VV; Yushchenko DA
Biochim Biophys Acta Proteins Proteom; 2019; 1867(7-8):701-709. PubMed ID: 31096048
[TBL] [Abstract][Full Text] [Related]
13. The C-terminal α-helices of mammalian Hsc70 play a critical role in the stabilization of α-synuclein binding and inhibition of aggregation.
Chaari A; Eliezer D; Ladjimi M
Int J Biol Macromol; 2016 Feb; 83():433-41. PubMed ID: 26601760
[TBL] [Abstract][Full Text] [Related]
14. Hsp70 molecular chaperones and Parkinson's disease.
Witt SN
Biopolymers; 2010 Mar; 93(3):218-28. PubMed ID: 19768775
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of α-Synuclein Fibril Elongation by Hsp70 Is Governed by a Kinetic Binding Competition between α-Synuclein Species.
Aprile FA; Arosio P; Fusco G; Chen SW; Kumita JR; Dhulesia A; Tortora P; Knowles TP; Vendruscolo M; Dobson CM; Cremades N
Biochemistry; 2017 Mar; 56(9):1177-1180. PubMed ID: 28230968
[TBL] [Abstract][Full Text] [Related]
16. HSP40 proteins use class-specific regulation to drive HSP70 functional diversity.
Faust O; Abayev-Avraham M; Wentink AS; Maurer M; Nillegoda NB; London N; Bukau B; Rosenzweig R
Nature; 2020 Nov; 587(7834):489-494. PubMed ID: 33177718
[TBL] [Abstract][Full Text] [Related]
17. The HSP110/HSP70 disaggregation system generates spreading-competent toxic α-synuclein species.
Tittelmeier J; Sandhof CA; Ries HM; Druffel-Augustin S; Mogk A; Bukau B; Nussbaum-Krammer C
EMBO J; 2020 Jul; 39(13):e103954. PubMed ID: 32449565
[TBL] [Abstract][Full Text] [Related]
18. All-or-none amyloid disassembly via chaperone-triggered fibril unzipping favors clearance of α-synuclein toxic species.
Franco A; Gracia P; Colom A; Camino JD; Fernández-Higuero JÁ; Orozco N; Dulebo A; Saiz L; Cremades N; Vilar JMG; Prado A; Muga A
Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34462355
[TBL] [Abstract][Full Text] [Related]
19. DnaK/DnaJ/GrpE of Hsp70 system have differing effects on alpha-synuclein fibrillation involved in Parkinson's disease.
Ahmad A
Int J Biol Macromol; 2010 Mar; 46(2):275-9. PubMed ID: 20060408
[TBL] [Abstract][Full Text] [Related]
20. N- and C-terminal regions of αB-crystallin and Hsp27 mediate inhibition of amyloid nucleation, fibril binding, and fibril disaggregation.
Selig EE; Zlatic CO; Cox D; Mok YF; Gooley PR; Ecroyd H; Griffin MDW
J Biol Chem; 2020 Jul; 295(29):9838-9854. PubMed ID: 32417755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
